Apotex Inc.
Records under this name other than the patents Apotex Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 48 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,703,156 | Liquid Formulation for Deferiprone with Palatable Taste Formerly held In force · High confidence | In force | High confidence | |
| US 10,780,055 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 10,940,115 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 10,940,116 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,357,731 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,607,389 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,723,874 | Delayed Release Deferiprone Tablets and Methods of Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,440,871 | Zuclomiphene Salts and Crystalline Forms Thereof Lapsed on the fee record Ended Sep 13, 2026 · High confidence | Lapsed on the fee record | Ended Sep 13, 2026 | High confidence |
| US 10,066,001 | Enhanced Liquid Formulation Stability of Erythropoietin Alpha Through Purification Processing Lapsed on the fee record Ended Sep 4, 2026 · High confidence | Lapsed on the fee record | Ended Sep 4, 2026 | High confidence |
| US 10,016,423 | Solid Forms of Nilotinib Hydrochloride Lapsed on the fee record Ended Jul 10, 2026 · High confidence | Lapsed on the fee record | Ended Jul 10, 2026 | High confidence |